20°C / 22°C
  • Thu
  • 16°C
  • 4°C
  • Fri
  • 18°C
  • 8°C
  • Sat
  • 19°C
  • 9°C
  • Sun
  • 21°C
  • 10°C
  • Mon
  • 22°C
  • 11°C
  • Thu
  • 17°C
  • 13°C
  • Fri
  • 18°C
  • 13°C
  • Sat
  • 20°C
  • 13°C
  • Sun
  • 23°C
  • 15°C
  • Mon
  • 21°C
  • 14°C
  • Thu
  • 18°C
  • 6°C
  • Fri
  • 21°C
  • 9°C
  • Sat
  • 22°C
  • 11°C
  • Sun
  • 22°C
  • 11°C
  • Mon
  • 24°C
  • 12°C
  • Thu
  • 16°C
  • 1°C
  • Fri
  • 19°C
  • 4°C
  • Sat
  • 20°C
  • 6°C
  • Sun
  • 22°C
  • 8°C
  • Mon
  • 23°C
  • 8°C
  • Thu
  • 21°C
  • 12°C
  • Fri
  • 25°C
  • 16°C
  • Sat
  • 21°C
  • 16°C
  • Sun
  • 25°C
  • 16°C
  • Mon
  • 26°C
  • 19°C
  • Thu
  • 21°C
  • 12°C
  • Fri
  • 17°C
  • 12°C
  • Sat
  • 17°C
  • 11°C
  • Sun
  • 25°C
  • 15°C
  • Mon
  • 21°C
  • 15°C
  • Thu
  • 14°C
  • 11°C
  • Fri
  • 19°C
  • 12°C
  • Sat
  • 24°C
  • 11°C
  • Sun
  • 26°C
  • 13°C
  • Mon
  • 24°C
  • 11°C
  • Thu
  • 16°C
  • 12°C
  • Fri
  • 18°C
  • 12°C
  • Sat
  • 21°C
  • 11°C
  • Sun
  • 24°C
  • 14°C
  • Mon
  • 22°C
  • 12°C
  • Thu
  • 19°C
  • 5°C
  • Fri
  • 23°C
  • 8°C
  • Sat
  • 23°C
  • 9°C
  • Sun
  • 23°C
  • 10°C
  • Mon
  • 25°C
  • 11°C
  • Thu
  • 15°C
  • -2°C
  • Fri
  • 18°C
  • 1°C
  • Sat
  • 20°C
  • 4°C
  • Sun
  • 22°C
  • 6°C
  • Mon
  • 23°C
  • 6°C
  • Thu
  • 23°C
  • 6°C
  • Fri
  • 28°C
  • 8°C
  • Sat
  • 24°C
  • 9°C
  • Sun
  • 27°C
  • 10°C
  • Mon
  • 29°C
  • 10°C
  • Thu
  • 18°C
  • 12°C
  • Fri
  • 16°C
  • 11°C
  • Sat
  • 17°C
  • 10°C
  • Sun
  • 22°C
  • 14°C
  • Mon
  • 19°C
  • 13°C

Competition Commission urged to urgently conclude cancer meds probe

This week, the Competition Commission announced that it is probing pharmaceutical companies, Aspen, Pfizer and Roche for various suspected transgressions.

Picture: Pixabay.com

JOHANNESBURG - In the wake of alleged excessive pricing of certain cancer medication in South Africa, cancer patients and relatives have appealed to the Competition Commission to urgently conclude its investigation into the matter as many people are in desperate need.

This week, the Competition Commission announced that it is probing pharmaceutical companies, Aspen, Pfizer and Roche for various suspected transgressions.

At the same time, on Wednesday an Italian court fined pharmaceutical giant Aspen €5.2 million plus interest after an appeal relating to its portfolio of oncology products distributed in that country was dismissed. Aspen was found to have used its dominance in the market while negotiating prices with that country’s drug regulator.

Cancer patients and relatives have told Eyewitness News they hope the investigation into alleged overpricing of the lifesaving medication will wrap up soon as they can’t afford the medication that can save their loved one’s lives.

“I’m really hopeful and hoping that something can come out of the investigation. The medicines are too expensive… we can’t afford it anymore.”

The Cancer Alliances’ Salome Meyer has called the Competition Commission to also investigate alleged price-fixing in the sector.

“We also have knowledge of other drugs and other companies that we will also take to the Competition Commission to investigate.”

(Edited by Zamangwane Shange)

Comments

EWN welcomes all comments that are constructive, contribute to discussions in a meaningful manner and take stories forward.

However, we will NOT condone the following:

- Racism (including offensive comments based on ethnicity and nationality)
- Sexism
- Homophobia
- Religious intolerance
- Cyber bullying
- Hate speech
- Derogatory language
- Comments inciting violence.

We ask that your comments remain relevant to the articles they appear on and do not include general banter or conversation as this dilutes the effectiveness of the comments section.

We strive to make the EWN community a safe and welcoming space for all.

EWN reserves the right to: 1) remove any comments that do not follow the above guidelines; and, 2) ban users who repeatedly infringe the rules.

Should you find any comments upsetting or offensive you can also flag them and we will assess it against our guidelines.

EWN is constantly reviewing its comments policy in order to create an environment conducive to constructive conversations.

comments powered by Disqus